Homepage
Catalog of Screening Compounds Screening Libraries Focused and Target Libraries Active Reference Sets Diversity Libraries
Screening Compounds Building blocks
Drug Discovery Services Custom Chemistry Medicinal chemistry In silico Drug Design (CADD) Discovery Biology Animal Models Toxicology and Safety ADME, DMPK Chemistry, Manufacturing and Controls
Company News & Media Contact us For suppliers Trends in discovery compounds
Homepage > Company > Media > Pharma News

Pharma News

Researchers develop synthetic, bacteria-killing virus
Researchers develop synthetic, bacteria-killing virus
Jan.
Puma Biotechnology sinks after Europe unlikely to OK breast cancer drug
Puma Biotechnology sinks after Europe unlikely to OK breast cancer drug
(Reuters) - Puma Biotechnology Inc said on Tuesday a European regulatory panel indicated it was unlikely to provide a positive opinion on the company’s breast cancer drug, sending its shares...
GW Pharmaceuticals and its U.S. Subsidiary Greenwich Biosciences Announce Publication of Landmark Epidiolex® (cannabidiol) Study in The Lancet
GW Pharmaceuticals and its U.S. Subsidiary Greenwich Biosciences Announce Publication of Landmark Epidiolex® (cannabidiol) Study in The Lancet
LONDON and CARLSBAD, Calif.
ChemoCentryx Announces Positive Overall Survival Results with CCR2 Inhibitor CCX872 for Locally Advanced/Metastatic Pancreatic Cancer
ChemoCentryx Announces Positive Overall Survival Results with CCR2 Inhibitor CCX872 for Locally Advanced/Metastatic Pancreatic Cancer
MOUNTAIN VIEW, Calif.
Teva Announces Top-Line Results from Phase III Studies of Subcutaneously Administered Reslizumab in Patients with Severe Eosinophilic Asthma
Teva Announces Top-Line Results from Phase III Studies of Subcutaneously Administered Reslizumab in Patients with Severe Eosinophilic Asthma
JERUSALEM--(BUSINESS WIRE)--Jan.
Eureka Therapeutics Closes $60 Million in Series D Financing to Advance Proprietary ARTEMIS™ T Cell Receptor Platform for Safer T Cell Therapies
Eureka Therapeutics Closes $60 Million in Series D Financing to Advance Proprietary ARTEMIS™ T Cell Receptor Platform for Safer T Cell Therapies
EMERYVILLE, Calif.
Lupin intros generic Vibra-Tabs
Lupin intros generic Vibra-Tabs
Lupin has introduced its generic Vibra-Tabs (doxycycline hyclate).
Celgene Corporation to Acquire Juno Therapeutics, Inc., Advancing Global Leadership in Cellular Immunotherapy
Celgene Corporation to Acquire Juno Therapeutics, Inc., Advancing Global Leadership in Cellular Immunotherapy
SUMMIT, N.
Sanofi to Acquire Bioverativ for $11.6 Billion ​
Sanofi to Acquire Bioverativ for $11.6 Billion ​
Paris (France) and Waltham, Mass.
Regen BioPharma, Inc.'s Medicinal Chemistry Program has Identified Additional Compounds That Activate NR2F6
Regen BioPharma, Inc.'s Medicinal Chemistry Program has Identified Additional Compounds That Activate NR2F6
Regen BioPharma, Inc.
Oral Contraceptive Balcoltra Gets FDA Approval
Oral Contraceptive Balcoltra Gets FDA Approval
Avion announced that the Food and Drug Administration (FDA) has approved Balcoltra (levonorgestrel and ethinyl estradiol tablets and ferrous bisglycinate tablets), a new oral contracep...
Amneal launches generic Entocort EC
Amneal launches generic Entocort EC
Amneal Pharmaceuticals on Thursday introduced its generic Entocort EC (budesonide capsules).
Catalog of Screening Compounds Screening Libraries Screening Compounds Building blocks
Drug Discovery Services News & Media Contact us
Payment systems
Policies & Terms     ©2023 ChemDiv     ChemistryOnDemand